NEW YORK, Sept. 6, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Physician Dispensed Cosmeceuticals Industryhttp://www.reportlinker.com/p0960404/Global-Physician-Dispensed-Cosmeceu...
This report analyzes the worldwide markets for Physician Dispensed Cosmeceuticals in US$ Million by the following major Product Segments: Physician Dispensed Skin Care Products, and Physician Dispensed Eyelash Products. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 73 companies including many key and niche players such as Allergan, Inc., Athena Cosmetics, Inc., Jan Marini Skin Research, Inc., Biopelle, Inc., Candem Pharma, Inc., Clinique Laboratories, LLC, exCel Manufacturing Co., Inc., Histogen, Inc., La Roche-Posay Laboratoire Pharmaceutique, Neutrogena Corporation, Obagi Medical Products, Inc., Pacific Bioscience Laboratories, Inc., SkinCeuticals, SkinMedica, Inc., Solta Medical, Inc., and Stiefel Laboratories, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Physician Dispensed Skin Care Products I-3Physician Dispensed Eyelash Products I-3II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
Physician Dispensed Cosmeceuticals: A Prelude II-1
Cosmeceuticals Market Remains Unscathed by Economical Woes II-1
Current and Future Analysis II-2
Market Dynamics II-2
Cosmeceutical Consumers: A Highly Informed Group II-2
The Mid-Life Crisis - A Key Growth Driver II-3
Women Account for Highest Spends on Skin Care II-3
Customizing Solutions for Uninsured Patients to go a Long Way II-4
Post Procedure Topical Products in Demand II-4
Physician Dispensing Outsmarts Conventional Retail Brands II-4
Manufacturers Widen Customer Base II-4
Innovative Ingredients Gain Focus II-5
Natural Ingredients Gain Attention II-5
What's Next in Ingredients II-6
Possible Ban on Hydroquinone Stimulates Search for Other
Pigment Control Products II-6
Skin Brightening and Lightening Products - A High Growth Market II-6
Companies Focus on Complementary Products II-7
Distribution Scenario II-7
E-Commerce to Reinforce Sales of Physician Dispensed Products II-8
Social Networking - A New Marketing Tool II-8
Competition II-8
Table 1: Leading Players in the Global Physician-Dispensed
Topical Skincare Products Eyelash Products (2010): Percentage
Breakdown of Revenues for Allergan Medical, Obagi,
SkinMedica, Skinceuticals, and Others (includes corresponding
Graph/Chart) II-9
Table 2: Leading Players in the Global Physician-DispensedEyelash Products (2010): Percentage Breakdown of Revenues forAllergan Medical, Athena Cosmetics, La Canada Ventures, andOthers (includes corresponding Graph/Chart) II-9
2. AESTHETICS MARKET: A BRIEF INSIGHT II-10
Historical and Recent Past Perspective II-10
Current Scenario, Outlook II-11
Aging Population: A Weighty Demographic Driver II-11
Societal Pressure to Look Young Peps Demand for Facial Aesthetics II-12
Undesirable Side Effects: A Challenge to Reckon With II-12
3. PRODUCT OVERVIEW II-13Introduction to Cosmeceuticals II-13Physician Dispensed Cosmeceuticals II-13Physician Dispensed Eyelash Products II-13Physician Dispensed Skin Care Products II-13Skin Care Products - An Overview II-13Moisturizers II-13Nourishers/Anti-Agers II-14Facial Cleansers II-14Sun Care Products II-14An Insight into Key Ingredients II-14Antioxidants II-14Hydroxy Acids (poly, beta, alpha) II-15Lightening Agents II-15Botanicals/ Plant Extracts II-15Proteins/Peptides II-15OTC Retinoids II-15Niacinamide II-15Topical Peptides II-15N-Acetyl Glucosamine II-16Competitive Aesthetic Procedures: Bulk Dermal Heating II-16Tissue Tightening Procedure using RF II-16BILD Procedure II-16
4. AN INSIGHT INTO THE MARKET BARRIERS II-17
Debate Surrounding Physician Dispensing of Cosmeceuticals II-17
Ethical Perspective II-17
Cost Related Issues II-17
Product Efficacy II-17
Emergence of Medispas II-18
Patient Discretion and Requirement II-18
Merits of Physician Dispensing II-18
Challenges II-19
5. RECENT INDUSTRY ACTIVITY II-20L'Oréal USA Acquires Pacific Bioscience Laboratories II-20Sanofi-Aventis Canada to Acquire Assets of Canderm Pharma II-20Solta Medical Acquires Aesthera II-20Biopelle Takes Over PRESCRIBEDsolutions II-21Neutraderm Enters into Distribute Deal for Dr. Susan Taylor'sRx for Brown Skin Product Line II-21
6. PRODUCT LAUNCHES II-22
Obagi Medical Products Launches Nu-Derm® Sun Shield SPF 50 And
Blue Peel RADIANCE™ II-22
GSK's Stiefel Launches REVALÉSKIN® HydraLift Complex Anti-
Aging Formula II-22
SkinMedica Introduces Biometa Essential SerumTM Anti-Aging
Solution II-22
SkinMedica Introduces Redness Relief CalmPlexTM Anti-Redness
Solution II-22
SkinMedica Rolls Out Tri-Retinol Complex ESTM Anti-Aging Cream II-23
Obagi Medical Products Launches ELASTILashTM Eyelash
Enhancement Solution II-23
Pacific Bioscience Laboratories Unveils Clarisonic® in Various
Regions II-23
Reliant Technologies Unveils Fraxel Skin Ecology System II-24
Pacific Bioscience Laboratories Launches Opal Sonic Infusion II-24
Timeless Skin Solutions Launches Latisse® II-24
7. FOCUS ON SELECT GLOBAL PLAYERS II-25Allergan, Inc. (The US) II-25Athena Cosmetics, Inc. (The US) II-26Jan Marini Skin Research, Inc. (The US) II-26Biopelle, Inc. (The US) II-26Candem Pharma, Inc. (Canada) II-26Clinique Laboratories, LLC (The US) II-27exCel Manufacturing Co., Inc. (The US) II-27Histogen, Inc. (The US) II-27La Roche-Posay Laboratoire Pharmaceutique (France) II-28Neutrogena Corporation (The US) II-28Obagi Medical Products, Inc. (The US) II-28Pacific Bioscience Laboratories, Inc. (The US) II-29SkinCeuticals (The US) II-29SkinMedica, Inc. (The US) II-29Solta Medical, Inc. (The US) II-30Stiefel Laboratories, Inc. (The US) II-30
8. GLOBAL MARKET PERSPECTIVE II-31
Table 3: World Recent Past, Present and Future Analysis for
Physician Dispensed Cosmeceuticals by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for the Years 2010 through 2018 (includes
corresponding Graph/Chart) II-31
Table 4: World Historic Review for Physician DispensedCosmeceuticals by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific, Latin America and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for the Years 2004 through 2009 (includescorresponding Graph/Chart) II-32
Table 5: World 15-Year Perspective for Physician Dispensed
Cosmeceuticals by Geographic Region - Percentage Breakdown of
Value Sales for - US, Canada, Japan, Europe, Asia-Pacific,
Latin America and Rest of World Markets for the Years 2004,
2011 and 2018 (includes corresponding Graph/Chart) II-33
By Product Segment II-34
Table 6: World Recent Past, Present and Future Analysis for
Physician Dispensed Skin Care Products by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific, Latin America and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for the Years 2010 through 2018
(includes corresponding Graph/Chart) II-34
Table 7: World Historic Review for Physician Dispensed SkinCare Products by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific, Latin America and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for the Years 2004 through 2009 (includescorresponding Graph/Chart) II-35
Table 8: World Recent Past, Present and Future Analysis for
Physician Dispensed Eyelash Products by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific, Latin America and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for the Years 2010 through 2018
(includes corresponding Graph/Chart) II-36
Table 9: World Historic Review for Physician Dispensed EyelashProducts by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific, Latin America and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for the Years 2004 through 2009 (includescorresponding Graph/Chart) II-37
Table 10: World 15-Year Perspective for Physician Dispensed
Skin Care Products by Geographic Region - Percentage Breakdown
of Value Sales for - US, Canada, Japan, Europe, Asia-Pacific,
Latin America and Rest of World Markets for the Years 2004,
2011 and 2018 (includes corresponding Graph/Chart) II-38
Table 11: World 15-Year Perspective for Physician DispensedEyelash Products by Geographic Region - Percentage Breakdownof Value Sales for - US, Canada, Japan, Europe, Asia-Pacific,Latin America and Rest of World Markets for the Years 2004,2011 and 2018 (includes corresponding Graph/Chart) II-39III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Physician-Dispensed Cosmeceuticals Market: Overview III-1
Competition III-1
US Aesthetics Market III-2
Major Trends III-2
FDA to Completely Ban Usage of Hydroquinone in Pigment
Controlling Products III-2
Ingredients for Skin Lightening Witness Surging Demand III-3
Strategic Corporate Developments III-3
Product Launches III-5
B.Market Analytics III-7
Table 12: US Recent Past, Current and Future Analysis for
Physician Dispensed Cosmeceuticals by Product Segment-
Eyelash Products and Skin Care Products Independently
Analyzed with Annual Sales Figures in US$ Million for the
Years 2010 through 2018 (includes corresponding Graph/Chart) III-7
Table 13: US Historic Review for Physician DispensedCosmeceuticals by Product Segment- Eyelash Products and SkinCare Products Independently Analyzed with Annual SalesFigures in US$ Million for the Years 2004 through 2009(includes corresponding Graph/Chart) III-8
Table 14: US 15-Year Perspective for Physician Dispensed
Cosmeceuticals by Product Segment - Percentage Breakdown of
Value Sales for Eyelash Products and Skin Care Products for
the Years 2004, 2011 and 2018 (includes corresponding
Graph/Chart) III-9
2. CANADA III-10A.Market Analysis III-10Outlook III-10Anti-Aging Products Market III-10B.Market Analytics III-11Table 15: Canadian Recent Past, Current and Future Analysisfor Physician Dispensed Cosmeceuticals by Product Segment-Eyelash Products and Skin Care Products IndependentlyAnalyzed with Annual Sales Figures in US$ Million for theYears 2010 through 2018 (includes corresponding Graph/Chart) III-11
Table 16: Canadian Historic Review for Physician Dispensed
Cosmeceuticals by Product Segment- Eyelash Products and Skin
Care Products Independently Analyzed with Annual Sales
Figures in US$ Million for the Years 2004 through 2009
(includes corresponding Graph/Chart) III-12
Table 17: Canadian 15-Year Perspective for PhysicianDispensed Cosmeceuticals by Product Segment - PercentageBreakdown of Value Sales for - Eyelash Products and SkinCare Products for the Years 2004, 2011 and 2018 (includescorresponding Graph/Chart) III-13
3. JAPAN III-14
A.Market Analysis III-14
Measuring the Potential of Anti-Ageing Products III-14
B.Market Analytics III-15
Table 18: Japanese Recent Past, Current and Future Analysis
for Physician Dispensed Cosmeceuticals by Product Segment-
Eyelash Products and Skin Care Products Independently
Analyzed with Annual Sales Figures in US$ Million for the
Years 2010 through 2018 (includes corresponding Graph/Chart) III-15
Table 19: Japanese Historic Review for Physician DispensedCosmeceuticals by Product Segment- Eyelash Products and SkinCare Products Independently Analyzed with Annual SalesFigures in US$ Million for the Years 2004 through 2009(includes corresponding Graph/Chart) III-16
Table 20: Japanese 15-Year Perspective for Physician
Dispensed Cosmeceuticals by Product Segment - Percentage
Breakdown of Value Sales for - Eyelash Products and Skin
Care Products for the Years 2004, 2011 and 2018 (includes
corresponding Graph/Chart) III-17
4. EUROPE III-18A.Market Analysis III-18Outlook III-18Skin Care market in Europe III-18B.Market Analytics III-19Table 21: European Recent Past, Present and Future Analysisfor Physician Dispensed Cosmeceuticals by Product Segment-Eyelash Products and Skin Care Products IndependentlyAnalyzed with Annual Sales Figures in US$ Million for theYears 2010 through 2018 (includes corresponding Graph/Chart) III-19
Table 22: European Historic Review for Physician Dispensed
Cosmeceuticals by Product Segment- Eyelash Products and Skin
Care Products Independently Analyzed with Annual Sales
Figures in US$ Million for the Years 2004 through 2009
(includes corresponding Graph/Chart) III-20
Table 23: European 15-Year Perspective for PhysicianDispensed Cosmeceuticals by Product Segment - PercentageBreakdown of Value Sales for Eyelash Products and Skin CareProducts for the Years 2004, 2011 and 2018 (includescorresponding Graph/Chart) III-21
5. ASIA-PACIFIC III-22
A.Market Analysis III-22
Current and Future Analysis III-22
Asian Aesthetics Market III-22
B.Market Analytics III-24
Table 24: Asia-Pacific Recent Past, Present and Future
Analysis for Physician Dispensed Cosmeceuticals by
Geographic Region - China, India and Rest of Asia-Pacific
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for the Years 2010 through 2018 (includes
corresponding Graph/Chart) III-24
Table 25: Asia-Pacific Historic Review for PhysicianDispensed Cosmeceuticals by Geographic Region - China, Indiaand Rest of Asia-Pacific Markets Independently Analyzed withAnnual Sales Figures in US$ Million for the Years 2004through 2009 (includes corresponding Graph/Chart) III-25
Table 26: Asia-Pacific Recent Past, Present and Future
Analysis for Physician Dispensed Cosmeceuticals by Product
Segment- Eyelash Products and Skin Care Products
Independently Analyzed with Annual Sales Figures in US$
Million for the Years 2010 through 2018 (includes
corresponding Graph/Chart) III-26
Table 27: Asia-Pacific Historic Review for PhysicianDispensed Cosmeceuticals by Product Segment- EyelashProducts and Skin Care Products Independently Analyzed withAnnual Sales Figures in US$ Million for the Years 2004through 2009 (includes corresponding Graph/Chart) III-27
Table 28: Asia-Pacific 15-Year Perspective for Physician
Dispensed Cosmeceuticals by Geographic Region - Percentage
Breakdown of Value Sales for - China, India and Rest of
Asia-Pacific Markets for the Years 2004, 2011 and 2018
(includes corresponding Graph/Chart) III-28
Table 29: Asia-Pacific 15-Year Perspective for PhysicianDispensed Cosmeceuticals by Product Segment- PercentageBreakdown of Value Sales for Eyelash Products and Skin CareProducts for the Years 2004, 2011 and 2018 (includescorresponding Graph/Chart) III-29
5a. CHINA III-30
Market Analysis III-30
Table 30: Chinese Recent Past, Present and Future Analysis
for Physician Dispensed Cosmeceuticals by Product Segment-
Eyelash Products and Skin Care Products Independently
Analyzed with Annual Sales Figures in US$ Million for the
Years 2010 through 2018 (includes corresponding Graph/Chart) III-30
Table 31: Chinese Historic Review for Physician DispensedCosmeceuticals by Product Segment- Eyelash Products and SkinCare Products Independently Analyzed with Annual SalesFigures in US$ Million for the Years 2004 through 2009(includes corresponding Graph/Chart) III-31
Table 32: Chinese 15-Year Perspective for Physician
Dispensed Cosmeceuticals by Product Segment - Percentage
Breakdown of Value Sales for Eyelash Products and Skin Care
Products for the Years 2004, 2011 and 2018 (includes
corresponding Graph/Chart) III-32
5b. INDIA III-33Market Analysis III-33Table 33: Indian Recent Past, Present and Future Analysisfor Physician Dispensed Cosmeceuticals by Product Segment-Eyelash Products and Skin Care Products IndependentlyAnalyzed with Annual Sales Figures in US$ Million for theYears 2010 through 2018 (includes corresponding Graph/Chart) III-33
Table 34: Indian Historic Review for Physician Dispensed
Cosmeceuticals by Product Segment- Eyelash Products and Skin
Care Products Independently Analyzed with Annual Sales
Figures in US$ Million for the Years 2004 through 2009
(includes corresponding Graph/Chart) III-34
Table 35: Indian 15-Year Perspective for Physician DispensedCosmeceuticals by Product Segment - Percentage Breakdown ofValue Sales for - Eyelash Products and Skin Care Productsfor the Years 2004, 2011 and 2018 (includes correspondingGraph/Chart) III-35
5c. REST OF ASIA-PACIFIC III-36
A.Market Analysis III-36
Outlook III-36
B.Market Analytics III-36
Table 36: Rest of Asia-Pacific Recent Past, Present and
Future Analysis for Physician Dispensed Cosmeceuticals by
Product Segment- Eyelash Products and Skin Care Products
Independently Analyzed with Annual Sales Figures in US$
Million for the Years 2010 through 2018 (includes
corresponding Graph/Chart) III-36
Table 37: Rest of Asia-Pacific Historic Review for PhysicianDispensed Cosmeceuticals by Product Segment- EyelashProducts and Skin Care Products Independently Analyzed withAnnual Sales Figures in US$ Million for the Years 2004through 2009 (includes corresponding Graph/Chart) III-37
Table 38: Rest of Asia-Pacific 15-Year Perspective for
Physician Dispensed Cosmeceuticals by Product Segment -
Percentage Breakdown of Value Sales for Eyelash Products and
Skin Care Products for the Years 2004, 2011 and 2018
(includes corresponding Graph/Chart) III-38
6. LATIN AMERICA III-39Market Analysis III-39Table 39: Latin America Recent Past, Present and FutureAnalysis for Physician Dispensed Cosmeceuticals byGeographic Region - Brazil, Mexico and Rest of Latin AmericaMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for the Years 2010 through 2018 (includescorresponding Graph/Chart) III-40
Table 40: Latin America Historic Review for Physician
Dispensed Cosmeceuticals by Geographic Region - Brazil,
Mexico and Rest of Latin America Markets Independently
Analyzed with Annual Sales Figures in US$ Million for the
Years 2004 through 2009 (includes corresponding Graph/Chart) III-41
Table 41: Latin America Recent Past, Present and FutureAnalysis for Physician Dispensed Cosmeceuticals by ProductSegment- Eyelash Products and Skin Care ProductsIndependently Analyzed with Annual Sales Figures in US$Million for the Years 2010 through 2018 (includescorresponding Graph/Chart) III-42
Table 42: Latin America Historic Review for Physician
Dispensed Cosmeceuticals by Product Segment- Eyelash
Products and Skin Care Products Independently Analyzed with
Annual Sales Figures in US$ Million for the Years 2004
through 2009 (includes corresponding Graph/Chart) III-43
Table 43: Latin America 15-Year Perspective for PhysicianDispensed Cosmeceuticals by Geographic Region - PercentageBreakdown of Value Sales for - Brazil, Mexico and Rest ofLatin America Markets for the Years 2004, 2011 and 2018(includes corresponding Graph/Chart) III-44
Table 44: Latin America 15-Year Perspective for Physician
Dispensed Cosmeceuticals by Product Segment - Percentage
Breakdown of Value Sales for Eyelash Products and Skin Care
Products for the Years 2004, 2011 and 2018 (includes
corresponding Graph/Chart) III-45
6a. BRAZIL III-46A.Market Analysis III-46Outlook III-46B.Market Analytics III-46Table 45: Brazilian Recent Past, Present and Future Analysisfor Physician Dispensed Cosmeceuticals by Product Segment-Eyelash Products and Skin Care Products IndependentlyAnalyzed with Annual Sales Figures in US$ Million for theYears 2010 through 2018 (includes corresponding Graph/Chart) III-46
Table 46: Brazilian Historic Review for Physician Dispensed
Cosmeceuticals by Product Segment- Eyelash Products and Skin
Care Products Independently Analyzed with Annual Sales
Figures in US$ Million for the Years 2004 through 2009
(includes corresponding Graph/Chart) III-47
Table 47: Brazilian 15-Year Perspective for PhysicianDispensed Cosmeceuticals by Product Segment - PercentageBreakdown of Value Sales for Eyelash Products and Skin CareProducts for the Years 2004, 2011 and 2018 (includescorresponding Graph/Chart) III-48
6b. MEXICO III-49
A.Market Analysis III-49
Outlook III-49
B.Market Analytics III-49
Table 48: Mexican Recent Past, Present and Future Analysis
for Physician Dispensed Cosmeceuticals by Product Segment-
Eyelash Products and Skin Care Products Independently
Analyzed with Annual Sales Figures in US$ Million for the
Years 2010 through 2018 (includes corresponding Graph/Chart) III-49
Table 49: Mexican Historic Review for Physician DispensedCosmeceuticals by Product Segment- Eyelash Products and SkinCare Products Independently Analyzed with Annual SalesFigures in US$ Million for the Years 2004 through 2009(includes corresponding Graph/Chart) III-50
Table 50: Mexican 15-Year Perspective for Physician
Dispensed Cosmeceuticals by Product Segment - Percentage
Breakdown of Value Sales for Eyelash Products and Skin Care
Products for the Years 2004, 2011 and 2018 (includes
corresponding Graph/Chart) III-51
6c. REST OF LATIN AMERICA III-52Market Analysis III-52Table 51: Rest of Latin America Recent Past, Present andFuture Analysis for Physician Dispensed Cosmeceuticals byProduct Segment- Eyelash Products and Skin Care ProductsIndependently Analyzed with Annual Sales Figures in US$Million for the Years 2010 through 2018 (includescorresponding Graph/Chart) III-52
Table 52: Rest of Latin America Historic Review for
Physician Dispensed Cosmeceuticals by Product Segment-
Eyelash Products and Skin Care Products Independently
Analyzed with Annual Sales Figures in US$ Million for the
Years 2004 through 2009 (includes corresponding Graph/Chart) III-53
Table 53: Rest of Latin America 15-Year Perspective forPhysician Dispensed Cosmeceuticals by Product Segment -Percentage Breakdown of Value Sales for Eyelash Products andSkin Care Products for the Years 2004, 2011 and 2018(includes corresponding Graph/Chart) III-54
7. REST OF WORLD III-55
Market Analysis III-55
Table 54: Rest of World Recent Past, Present and Future
Analysis for Physician Dispensed Cosmeceuticals by Product
Segment- Eyelash Products and Skin Care Products
Independently Analyzed with Annual Sales Figures in US$
Million for the Years 2010 through 2018 (includes
corresponding Graph/Chart) III-55
Table 55: Rest of World Historic Review for PhysicianDispensed Cosmeceuticals by Product Segment- EyelashProducts and Skin Care Products Independently Analyzed withAnnual Sales Figures in US$ Million for the Years 2004through 2009 (includes corresponding Graph/Chart) III-56
Table 56: Rest of World 15-Year Perspective for Physician
Dispensed Cosmeceuticals by Product Segment - Percentage
Breakdown of Value Sales for Eyelash Products and Skin Care
Products for the Years 2004, 2011 and 2018 (includes
corresponding Graph/Chart) III-57
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 73 (including Divisions/Subsidiaries - 80)
The United States (64)Canada (3)Europe (10)- France (9)- Rest of Europe (1)Asia-Pacific (Excluding Japan) (1)Africa (1)Middle East (1)
To order this report:Skin_Care_Products Industry: Global Physician Dispensed Cosmeceuticals Industry
Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
